|
End-of-day quote
Korea S.E.
2026-08-20
|
5-day change | 1st Jan Change | ||
| 22,150.00 KRW | +8.31% |
|
+3.75% | -61.41% |
| 07-23 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 12-21 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
Chart: Technical Analysis
Stock exchange
Korea S.E.
A287840 22,150.00 ₩
+8.31%
1.47B
₩
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Korea S.E.
| A287840 | 22,150.00KRW | +8.31% | 1.47B ₩ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 24,300 | 24,300 | 37,300 |
| Spread/Res. | -8.85% | -8.85% | -40.62% |
| Spread/Supp. | +59.93% | +59.93% | +36.90% |
| Support | 13,850 | 13,850 | 16,180 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A287840 Stock
- Charts IntoCell, Inc.
Select your edition
All financial news and data tailored to specific country editions
